Q&M Dental secures medical device licenses in key SEA markets

The company will now be able to sell and distribute in Thailand, the Philippines, Vietnam, and Indonesia.

Q&M Dental Group, through its 49% associated company EM2AI, has received medical device licenses for its dental artificial intelligence solutions (AI) in key Southeast Asian markets.

These include a Category 2 Medical Device License from the Food and Drug Administration (FDA) of Thailand; Class B licenses from the FDA of the Philippines and the Department of Medical Equipment of Vietnam; and a Class C license from the Ministry of Health of Indonesia.

Currently, EM2AI only sells and distributes its AI solutions in Singapore and Malaysia.

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia